Literature DB >> 23859626

The disproportionate economic burden associated with severe and complicated obesity: a systematic review.

E Grieve1, E Fenwick, H-C Yang, M Lean.   

Abstract

Burden of disease studies typically classify individuals with a body mass index (BMI) ≥ 30 kg m(-2) as a single group ('obese') and make comparisons to those with lower BMIs. Here, we review the literature on the additional economic burden associated with severe obesity or classes 3 and 4 obesity (BMI ≥ 40 kg m(-2) ), the fastest growing category of obesity, with the aim of exploring and disaggregating differences in resource use as BMI increases beyond 40 kg m(-2) . We recognize the importance of comparing classes 3 and 4 obesity to less severe obesity (classes 1 and 2) as well as quantifying the single sub-class impacts (classes 3 and 4). Although the latter analysis is the aim of this review, we include results, where found in the literature, for movement between the recognized subclasses and within classes 3 and 4 obesity. Articles presenting data on the economic burden associated with severe obesity were identified from a search of Ovid MEDLINE, EMBASE, EBSCO CINAHL and Cochrane Library databases. Data were extracted on the direct costs, productivity costs and resource use associated with severe obesity along with estimates of the multiplier effects associated with increasing BMI. Fifteen studies were identified, of which four disaggregated resource use for BMI ≥ 40 kg m(-2) . The multiplier effects derived for a variety of different types of costs incurred by the severely obese compared with those of normal weight (18.5 kg m(-2)  < BMI < 25 kg m(-2) ) ranged from 1.5 to 3.9 for direct costs, and from 1.7 to 8.0 for productivity costs. There are few published data on the economic burden of obesity disaggregated by BMI ≥ 40 kg m(-2) . By grouping people homogenously above a threshold of BMI 40 kg m(-2) , the multiplier effects for those at the highest end of the spectrum are likely to be underestimated. This will, in turn, impact on the estimates of cost-effectiveness for interventions and policies aimed at the severely obese.
© 2013 The Authors. obesity reviews © 2013 International Association for the Study of Obesity.

Entities:  

Keywords:  Healthcare costs; productivity costs; resource use; severe obesity

Mesh:

Year:  2013        PMID: 23859626     DOI: 10.1111/obr.12059

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  28 in total

1.  Intraoperative Ventilation of Morbidly Obese Patients Guided by Transpulmonary Pressure.

Authors:  Lars Eichler; Katarzyna Truskowska; A Dupree; P Busch; Alwin E Goetz; Christian Zöllner
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

2.  The Inequity of Bariatric Surgery: Publicly Insured Patients Undergo Lower Rates of Bariatric Surgery with Worse Outcomes.

Authors:  Dietric L Hennings; Maria Baimas-George; Zaid Al-Quarayshi; Rachel Moore; Emad Kandil; Christopher G DuCoin
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

Review 3.  Pharmacotherapy for obesity: novel agents and paradigms.

Authors:  Sean Manning; Andrea Pucci; Nicholas Finer
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

4.  Improving Medication Dosing in the Obese Patient.

Authors:  Brian L Erstad
Journal:  Clin Drug Investig       Date:  2017-01       Impact factor: 2.859

Review 5.  Bariatric and metabolic surgery: a shift in eligibility and success criteria.

Authors:  Gema Frühbeck
Journal:  Nat Rev Endocrinol       Date:  2015-06-09       Impact factor: 43.330

6.  Healthcare utilization associated with obesity and physical disabilities.

Authors:  Mark D Peterson; Elham Mahmoudi
Journal:  Am J Prev Med       Date:  2015-02-21       Impact factor: 5.043

7.  Child Maltreatment and the Adolescent Patient With Severe Obesity: Implications for Clinical Care.

Authors:  Meg H Zeller; Jennie G Noll; David B Sarwer; Jennifer Reiter-Purtill; Dana L Rofey; Amy E Baughcum; James Peugh; Anita P Courcoulas; Marc P Michalsky; Todd M Jenkins; Jennifer N Becnel
Journal:  J Pediatr Psychol       Date:  2015-03-15

Review 8.  The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.

Authors:  Abdulmaged M Traish; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 9.  Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis.

Authors:  Jianfang Li; Dandan Lai; Dongping Wu
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

10.  Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.

Authors:  Francesco Suriano; Sara Vieira-Silva; Gwen Falony; Martin Roumain; Adrien Paquot; Rudy Pelicaen; Marion Régnier; Nathalie M Delzenne; Jeroen Raes; Giulio G Muccioli; Matthias Van Hul; Patrice D Cani
Journal:  Microbiome       Date:  2021-06-28       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.